4.7 Article

Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome

Related references

Note: Only part of the references are listed.
Review Pediatrics

Rituximab in children with steroid sensitive nephrotic syndrome: in quest of the optimal regimen

Eugene Yu-hin Chan et al.

Summary: Rituximab has been proven as an effective therapy for children with complicated frequently relapsing and steroid-dependent nephrotic syndrome, with considerations on dosing, patient factors, and maintenance immunosuppression affecting treatment outcomes. Patients with more severe disease may have poorer response to rituximab and may experience chronic hypogammaglobulinemia and impaired immunity. Reliable prognostic and biomarkers for guiding subsequent treatments are yet to be identified.

PEDIATRIC NEPHROLOGY (2021)

Review Pediatrics

Rituximab Use in the Management of Childhood Nephrotic Syndrome

Mahmoud Kallash et al.

FRONTIERS IN PEDIATRICS (2019)

Article Multidisciplinary Sciences

Analysis of the B cell receptor repertoire in six immune-mediated diseases

R. J. M. Bashford-Rogers et al.

NATURE (2019)

Review Pediatrics

Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials

Kazumoto Iijima et al.

PEDIATRIC NEPHROLOGY (2018)

Review Medicine, General & Internal

Idiopathic nephrotic syndrome in children

Damien G. Noone et al.

LANCET (2018)

Article Urology & Nephrology

High incidence of idiopathic nephrotic syndrome in East Asian children: a nationwide survey in Japan (JP-SHINE study)

Kaori Kikunaga et al.

CLINICAL AND EXPERIMENTAL NEPHROLOGY (2017)

Article Urology & Nephrology

B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome

Manuela Colucci et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

Article Urology & Nephrology

Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy

Kenji Ishikura et al.

CLINICAL AND EXPERIMENTAL NEPHROLOGY (2015)

Editorial Material Pediatrics

Should we consider MMF therapy after rituximab for nephrotic syndrome?

Guido Filler et al.

PEDIATRIC NEPHROLOGY (2011)

Article Transplantation

Treatment with microemulsified cyclosporine in children with frequently relapsing nephrotic syndrome

Kenji Ishikura et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)

Article Pediatrics

Mycophenolate mofetil therapy for children with intractable nephrotic syndrome

Mitsuru Okada et al.

PEDIATRICS INTERNATIONAL (2007)

Article Urology & Nephrology

Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: A report from the southwest pediatric nephrology study group

Ronald J. Hogg et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)

Article Pediatrics

Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome

S Mendizábal et al.

PEDIATRIC NEPHROLOGY (2005)

Article Pediatrics

Switch from cyclosporine A to mycophenolate mofetil in nephrotic children

T Ulinski et al.

PEDIATRIC NEPHROLOGY (2005)

Article Pediatrics

Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil

J Gellermann et al.

PEDIATRIC NEPHROLOGY (2004)

Article Urology & Nephrology

Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome

A Bagga et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2003)

Article Medicine, General & Internal

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis

TM Chan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)

Article Statistics & Probability

Semiparametric regression for the mean and rate functions of recurrent events

DY Lin et al.

JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2000)